Executive Director
Merck & Co.
Dr. Matthew Rizk, PhD, is currently an Executive Director in the department of Quantitative Pharmacology & Pharmacometrics (QP2) at Merck & Co., Inc. Matt received his BS from Cornell University and his PhD from UCLA, both in Chemical Engineering, with research focused in the areas of metabolic engineering and synthetic biology. He then joined Merck Research Laboratories in 2009, where he is currently the QP2 TA head for infectious disease, vaccines and cardiometabolic disease. He has been a member of ASCPT since 2010 and is currently serving on the Board of Directors.